From: Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment
Characteristics
Number (%)
Patient No.
96 (100)
Adverse event
Cold Sensation
6 (6.3)
Irritation
3 (3.1)
Itching
Rash
Redness
1 (1.0)